Pescarmona, R., Mouton, W., Walzer, T., Dalle, S., Eberhardt, A., Brengel-Pesce, K., . . . Viel, S. (2021). Evaluation of TTV replication as a biomarker of immune checkpoint inhibitors efficacy in melanoma patients. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Pescarmona, Rémi, et al. Evaluation of TTV Replication as a Biomarker of Immune Checkpoint Inhibitors Efficacy in Melanoma Patients. Public Library of Science (PLoS), 2021.
Cita MLA (8a ed.)Pescarmona, Rémi, et al. Evaluation of TTV Replication as a Biomarker of Immune Checkpoint Inhibitors Efficacy in Melanoma Patients. Public Library of Science (PLoS), 2021.
Precaución: Estas citas no son 100% exactas.